RATIONALE: In major depression, prefrontal regulation of limbic brain areas may be a key mechanism that is impaired during the processing of affective information. This prefrontal-limbic interaction has been shown to be modulated by serotonin (5-HTT) genotype, indicating a higher risk for major depressive disorder (MDD) with increasing number of 5-HTT low-expression alleles. OBJECTIVE: Functional magnetic resonance imaging was used to assess neural response to uncued unpleasant affective pictures in 21 unmedicated patients with MDD compared to 21 matched healthy controls, taking into account genetic influences of the 5-HTT (SCL6A4) high- and low-expression genotype. RESULTS: Healthy controls displayed greater prefrontal activation (BA10) to uncued negative pictures compared to patients with MDD. While in healthy controls prefrontal (BA10) activation and BA10-amygdala coupling increased with the number of 5-HTT low-expression risk alleles, this effect was abolished, and even reversed, in patients with MDD. In MDD, connectivity decreased with severity of depressive symptoms (HAMD total score). CONCLUSION: These findings suggest that increased medial prefrontal (BA10) activation and BA10-amygdala connectivity may counteract the risk for MDD in healthy carriers of 5-HTT low-expression alleles, while this protective factor might be lost in patients who actually suffer from MDD. Prefrontal-limbic regulation in risk populations could be a target of early interventions and should be the focus of further research.
RATIONALE: In major depression, prefrontal regulation of limbic brain areas may be a key mechanism that is impaired during the processing of affective information. This prefrontal-limbic interaction has been shown to be modulated by serotonin (5-HTT) genotype, indicating a higher risk for major depressive disorder (MDD) with increasing number of 5-HTT low-expression alleles. OBJECTIVE: Functional magnetic resonance imaging was used to assess neural response to uncued unpleasant affective pictures in 21 unmedicated patients with MDD compared to 21 matched healthy controls, taking into account genetic influences of the 5-HTT (SCL6A4) high- and low-expression genotype. RESULTS: Healthy controls displayed greater prefrontal activation (BA10) to uncued negative pictures compared to patients with MDD. While in healthy controls prefrontal (BA10) activation and BA10-amygdala coupling increased with the number of 5-HTT low-expression risk alleles, this effect was abolished, and even reversed, in patients with MDD. In MDD, connectivity decreased with severity of depressive symptoms (HAMD total score). CONCLUSION: These findings suggest that increased medial prefrontal (BA10) activation and BA10-amygdala connectivity may counteract the risk for MDD in healthy carriers of 5-HTT low-expression alleles, while this protective factor might be lost in patients who actually suffer from MDD. Prefrontal-limbic regulation in risk populations could be a target of early interventions and should be the focus of further research.
Authors: Paul A Keedwell; Chris Andrew; Steven C R Williams; Mick J Brammer; Mary L Phillips Journal: Biol Psychiatry Date: 2005-07-05 Impact factor: 13.382
Authors: Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman Journal: Am J Hum Genet Date: 2006-03-28 Impact factor: 11.025
Authors: Greg J Siegle; Stuart R Steinhauer; Michael E Thase; V Andrew Stenger; Cameron S Carter Journal: Biol Psychiatry Date: 2002-05-01 Impact factor: 13.382
Authors: Amit Anand; Yu Li; Yang Wang; Jingwei Wu; Sujuan Gao; Lubna Bukhari; Vincent P Mathews; Andrew Kalnin; Mark J Lowe Journal: Neuropsychopharmacology Date: 2005-07 Impact factor: 7.853
Authors: Martina T Mitterschiffthaler; Ulrich Ettinger; Mitul A Mehta; David Mataix-Cols; Steve C R Williams Journal: J Magn Reson Imaging Date: 2006-06 Impact factor: 4.813
Authors: D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Isaac T Petersen; John E Bates; Jackson A Goodnight; Kenneth A Dodge; Jennifer E Lansford; Gregory S Pettit; Shawn J Latendresse; Danielle M Dick Journal: Dev Psychol Date: 2012-03-05
Authors: Seth J Gillihan; Hengyi Rao; Lauretta Brennan; Danny J J Wang; John A Detre; Geena Mary V Sankoorikal; Edward S Brodkin; Martha J Farah Journal: Psychiatry Res Date: 2011-07-20 Impact factor: 3.222
Authors: Tiffany C Ho; Colm G Connolly; Eva Henje Blom; Kaja Z LeWinn; Irina A Strigo; Martin P Paulus; Guido Frank; Jeffrey E Max; Jing Wu; Melanie Chan; Susan F Tapert; Alan N Simmons; Tony T Yang Journal: Biol Psychiatry Date: 2014-09-16 Impact factor: 13.382
Authors: Esther M Opmeer; Rudie Kortekaas; Marie-José van Tol; Nic J A van der Wee; Saskia Woudstra; Mark A van Buchem; Brenda W J H Penninx; Dick J Veltman; André Aleman Journal: Soc Cogn Affect Neurosci Date: 2013-03-11 Impact factor: 3.436